- Home
- SVT vs TOI Comparison
SVT vs TOI Comparison
Compare SVT & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVT
- TOI
- Stock Information
- Founded
- SVT 1959
- TOI 2007
- Country
- SVT United States
- TOI United States
- Employees
- SVT N/A
- TOI N/A
- Industry
- SVT Industrial Machinery/Components
- TOI Medical/Nursing Services
- Sector
- SVT Consumer Discretionary
- TOI Health Care
- Exchange
- SVT Nasdaq
- TOI Nasdaq
- Market Cap
- SVT 27.1M
- TOI 22.6M
- IPO Year
- SVT N/A
- TOI N/A
- Fundamental
- Price
- SVT $10.60
- TOI $0.89
- Analyst Decision
- SVT
- TOI Strong Buy
- Analyst Count
- SVT 0
- TOI 1
- Target Price
- SVT N/A
- TOI $2.50
- AVG Volume (30 Days)
- SVT 1.7K
- TOI 721.3K
- Earning Date
- SVT 03-21-2025
- TOI 03-26-2025
- Dividend Yield
- SVT N/A
- TOI N/A
- EPS Growth
- SVT N/A
- TOI N/A
- EPS
- SVT 0.05
- TOI N/A
- Revenue
- SVT $47,487,000.00
- TOI $378,933,000.00
- Revenue This Year
- SVT N/A
- TOI $29.17
- Revenue Next Year
- SVT N/A
- TOI $16.43
- P/E Ratio
- SVT $223.96
- TOI N/A
- Revenue Growth
- SVT 19.50
- TOI 22.29
- 52 Week Low
- SVT $10.16
- TOI $0.13
- 52 Week High
- SVT $13.85
- TOI $2.10
- Technical
- Relative Strength Index (RSI)
- SVT 47.50
- TOI 58.58
- Support Level
- SVT $10.26
- TOI $0.88
- Resistance Level
- SVT $10.66
- TOI $1.07
- Average True Range (ATR)
- SVT 0.34
- TOI 0.12
- MACD
- SVT -0.04
- TOI -0.02
- Stochastic Oscillator
- SVT 36.50
- TOI 36.56
About SVT Servotronics Inc.
Servotronics Inc is a U.S based company that designs, manufactures, and markets servo valves, including torque motor, hydraulic, and pneumatic valves. The company has single reportable segment which is aerospace Its products are marketed and sold throughout the United States and in select foreign markets. These products are sold to commercial aviation manufacturers, government prime contractors, government subcontractors, and end-users.
About TOI The Oncology Institute Inc.
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services.